Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-Label Study of Nipent, Cytoxan and Rituxan in Patients With Previously Untreated or Treated Chronic Lymphocytic Leukemia.

NCT00131313 is registered in ClinicalTrials.gov with East Valley Hematology and Oncology Medical Group as lead sponsor.

NCT NCT00131313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00131313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-Label Study of Nipent, Cytoxan and Rituxan in Patients With Previously Untreated or Treated Chronic Lymphocytic Leukemia.
Lead sponsor
East Valley Hematology and Oncology Medical Group
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2003
Completion date
April 30, 2009
Enrollment
180
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia